{"id":1048017,"title":"DSEN Abstract: Ondansetron use during pregnancy: Utilization and adverse outcomes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-11","captureTimestamp":"2026-03-11T14:10:30.795000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53882.html?wbdisable=true","snippet":"DSEN Abstract Ondansetron use during pregnancy: Utilization and adverse outcomes (Q16-08) A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) In this large study of 4,103,695 pregnancies, ondansetron use during pregnancy was not associated…","rawSnapshotUrl":"/api/snapshots/raw/1048017","browseUrl":"https://replay.healtharchive.ca/job-8/20260311141030/https://cihr-irsc.gc.ca/e/53882.html?wbdisable=true#ha_snapshot=1048017","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}